These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 14580096)
1. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging. Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096 [TBL] [Abstract][Full Text] [Related]
2. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM; Kim CS; Youk JH; Lee MS Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708 [TBL] [Abstract][Full Text] [Related]
5. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899 [TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
7. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging. Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950 [TBL] [Abstract][Full Text] [Related]
8. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259 [TBL] [Abstract][Full Text] [Related]
9. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners. Limanond P; Raman SS; Sayre J; Lu DS J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231 [TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [TBL] [Abstract][Full Text] [Related]